Curis, Inc. to Release First Quarter 2009 Financial Results and Hold Conference Call on May 5, 2009

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will release its first quarter financial results on Tuesday, May 5, 2009 before the market opens. The Company will also hold a conference call on the same day at 9:00 A.M. Eastern time to discuss: (i) its Hedgehog pathway inhibitor program under collaboration with Genentech, (ii) CUDC-101, CUDC-305 and other proprietary targeted cancer programs, (iii) its financial results as of and for the first quarter ended March 31, 2009, and (iv) additional corporate activities. Daniel Passeri, President and Chief Executive Officer of Curis, will host the call.

Back to news